AR and neoplasm: LIN28A promoted cell proliferation and invasion and suppressed cell apoptosis in ER−/Her2+ breast cancer cells and accelerated breast cancer xenograft tumor growth in vivo by activating androgen receptor (AR) via recruiting c-myc to AR promoter region (44).